While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective.

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.

The FDA approved the PD-1 inhibitor penpulimab, with two indications, for treating non-keratinizing nasopharyngeal carcinoma ...

Fred Hutch oncologists found evidence of a tumor overlooked by others that extended from the base of the skull to the ear and ...